We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

89 hedge funds and large institutions have $313M invested in MacroGenics in 2014 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 14

100% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 14

19% more funds holding

Funds holding: 75 → 89 (+14)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

21% less capital invested

Capital invested by funds: $397M → $313M (-$84.7M)

Holders
89
Holders Change
+14
Holders Change %
+18.67%
% of All Funds
2.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
44
Reduced
14
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$27.3M
2
First Eagle Investment Management
First Eagle Investment Management
New York
+$7.03M
3
PCA
Private Capital Advisors
Connecticut
+$6.97M
4
BFA
BlackRock Fund Advisors
California
+$6.68M
5
BIT
BlackRock Institutional Trust
California
+$4.64M

Top Sellers

1
MAM
MPM Asset Management
Massachusetts
-$37.4M
2
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
-$30.9M
3
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$20.8M
4
O
OrbiMed
New York
-$13.7M
5
PHS
PFM Health Sciences
California
-$5.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
101
PDT Partners
New York
– -$407K -14,623 Closed
Marshall Wace
102
Marshall Wace
United Kingdom
– -$278K -10,000 Closed
PIM
103
Partner Investment Management
California
– -$229K -8,211 Closed
1 2 3 4
5

MGNX Hedge Fund Activity: Q2 2014 in Review

89 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2014, worth a combined $313M — down 21% from $397M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new MGNX positions and 14 closed out — a net gain of 14 holders — while 44 added to existing stakes and 14 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $27.3M. The largest seller was MPM Asset Management, cutting an estimated $37.4M.

  • 89 institutional investors held MacroGenics (MGNX) as of Q2 2014, up from 75 in Q1 2014.
  • Funds reported $313M of MacroGenics stock for Q2 2014, down 21% quarter-over-quarter.
  • 28 funds opened new MacroGenics positions in Q2 2014 and 14 closed out, a net change of +14 holders.
  • The largest MacroGenics buyer in Q2 2014 was Fidelity Investments, an estimated $27.3M added.
  • The largest MacroGenics seller in Q2 2014 was MPM Asset Management, an estimated $37.4M sold.

Based on aggregated 13F filings for Q2 2014.